HutchMed Set to Lead China Biotech Fundraising In June

PE Also Strong

The China-based biopharma company is seeking up to $602.8m gross in its Hong Kong IPO.

fund raising
HutchMed Set to Lead China Biotech Fund-Raising In June • Source: Alamy

More from Financing

More from Business